Abstract

Each step of the cell life and its response or adaptation to its environment are mediated by a network of protein/protein interactions termed “interactome.” Our knowledge of this network keeps growing due to the development of sensitive techniques devoted to study these interactions. The bioluminescence resonance energy transfer (BRET) technique was primarily developed to allow the dynamic monitoring of protein/protein interactions (PPI) in living cells, and has widely been used to study receptor activation by intra- or extra-molecular conformational changes within receptors and activated complexes in mammal cells. Some interactions are described as crucial in human pathological processes, and a new class of drugs targeting them has recently emerged. The BRET method is well suited to identify inhibitors of PPI and here is described why and how to set up and optimize a high throughput screening assay based on BRET to search for such inhibitory compounds. The different parameters to take into account when developing such BRET assays in mammal cells are reviewed to give general guidelines: considerations on the targeted interaction, choice of BRET version, inducibility of the interaction, kinetic of the monitored interaction, and of the BRET reading, influence of substrate concentration, number of cells and medium composition used on the Z′ factor, and expected interferences from colored or fluorescent compounds.

Highlights

  • Protein/protein interactions (PPI) govern all key events in a cell life, from division, to adaption or response to extracellular signals leading to biological effects

  • This study showed for the first time a real success for such P2I2 bioluminescence resonance energy transfer (BRET)-based screening assays

  • Bioluminescence resonance energy transfer technique is well suited to set up high throughput P2I2 screening assays

Read more

Summary

INTRODUCTION

Protein/protein interactions (PPI) govern all key events in a cell life, from division, to adaption or response to extracellular signals leading to biological effects. Deciphering that a fine PPI change can lead to a drastic PPI network modification was the bases of a pathological state, has opened new views for drug discovery Applying this concept by using the current knowledge of protein interaction network modification in glioblastoma cancer cells, a recent study allowed the successful screening of inhibitory peptide disrupting PIKE-A/Akt and their capacity to inhibit the proliferation of these cells (Qi et al, 2012). The need for robust and high throughput screening (HTS) compatible method, when performing screening assays, has lead to the preferential use of techniques www.frontiersin.org

Couturier and Deprez
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.